← Back to Analyst Consensus 
EW Buy
Edwards Lifesciences Corp
Current Price —
Implied Upside —
Analysts 38
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Barclays | initiate | — → Overweight | — | 53% |
| Sep 11, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jul 24, 2026 | Leerink Partners | upgrade | Market Perform → Outperform | — | 51% |
| Jul 24, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 24, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Jul 16, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 13, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 8, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Jun 30, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 16, 2026 | RBC Capital | reiterate | Outperform → Outperform | — | 55% |
| Jun 2, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 27, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 24, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Apr 24, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Apr 24, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Apr 24, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Apr 24, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Apr 6, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Feb 11, 2026 | Goldman Sachs | maintain | Buy → Buy | $95 | 54% |
| Feb 11, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $100 | 54% |
| Feb 11, 2026 | Truist Securities | maintain | Hold → Hold | $89 | 54% |
| Feb 11, 2026 | Wells Fargo | maintain | Overweight → Overweight | $100 | 54% |
| Feb 11, 2026 | BTIG | reiterate | Buy → Buy | $103 | 52% |
| Jan 20, 2026 | Stifel | maintain | Buy → Buy | $110 | 53% |
| Jan 20, 2026 | Piper Sandler | maintain | Overweight → Overweight | $98 | 54% |
| Jan 12, 2026 | UBS | maintain | Neutral → Neutral | $95 | 54% |
| Jan 12, 2026 | Barclays | maintain | Overweight → Overweight | $104 | 53% |
| Jan 9, 2026 | TD Cowen | upgrade | Hold → Buy | $97 | 54% |
| Jan 7, 2026 | Stifel | maintain | Buy → Buy | $105 | 53% |
| Dec 18, 2025 | JP Morgan | upgrade | Neutral → Overweight | $100 | 54% |
| Dec 17, 2025 | Canaccord Genuity | maintain | Hold → Hold | $87 | 48% |
| Dec 16, 2025 | Baird | maintain | Neutral → Neutral | $87 | 55% |
| Dec 11, 2025 | Citigroup | maintain | Buy → Buy | $101 | 54% |
| Dec 8, 2025 | Barclays | maintain | Overweight → Overweight | $103 | 53% |
| Dec 5, 2025 | Canaccord Genuity | maintain | Hold → Hold | $89 | 48% |
| Dec 5, 2025 | Stifel | maintain | Buy → Buy | $100 | 53% |
| Dec 5, 2025 | UBS | maintain | Neutral → Neutral | $92 | 54% |
| Dec 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $96 | 54% |
| Dec 5, 2025 | Truist Securities | maintain | Hold → Hold | $92 | 54% |
| Dec 5, 2025 | RBC Capital | maintain | Outperform → Outperform | $100 | 55% |
| Dec 5, 2025 | Baird | maintain | Neutral → Neutral | $88 | 55% |
| Dec 5, 2025 | BTIG | maintain | Buy → Buy | $103 | 52% |
| Nov 25, 2025 | BTIG | reiterate | Buy → Buy | $100 | 52% |
| Nov 3, 2025 | Truist Securities | maintain | Hold → Hold | $90 | 54% |
| Nov 3, 2025 | Canaccord Genuity | maintain | Hold → Hold | $84 | 48% |
| Oct 31, 2025 | Barclays | maintain | Overweight → Overweight | $99 | 53% |
| Oct 31, 2025 | Citigroup | maintain | Buy → Buy | $96 | 54% |
Price Target Trend
Jul 21, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days